📊 Score Breakdown
Offering Ability
40
Cash Runway
10
Float Risk
45
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
7%
📉 Score Deterioration
15%
• Score climbed 5 points (worsening)
💹 Market Data
Market Cap$1.52B
Shares Outstanding16.68M
Float9.83M
Cash$562.48M
Debt$30.02M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 4.0% shares (2025Q4 vs prior)
195 institutional holders · 378.75M shares
#1
Clayton, Dubilier & Rice, LLC
100.00M shares
#2
MORGAN STANLEY
53.88M shares
#3
North Peak Capital Management, LLC
38.14M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest791.5K
Days to Cover1.9
% of Float8.1%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2021
4
INSIDER TRANSACTION
Apr 16, 2026
4
INSIDER TRANSACTION
Apr 16, 2026
4
INSIDER TRANSACTION
Apr 03, 2026
4
INSIDER TRANSACTION
Apr 03, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for AGL
📊 AGL FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 AGL Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.